Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy

To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients

NCT03655210 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis

NCT01160861 ·Status: COMPLETED ·Phase: PHASE1

Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis

NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy

NCT01675882 ·Status: COMPLETED ·Phase: PHASE2

Oral Immunotherapy for Peanut Allergic Patients

NCT04163562 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis

NCT01949051 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients

NCT03463135 ·Status: COMPLETED ·Phase: PHASE1

A Study in Subjects With Perennial Allergic Rhinitis

NCT00210015 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

NCT00836914 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

NCT01804400 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Effects of Single Dose Corticosteroids on Response to Allergens

NCT00828061 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of rEV131 in Allergic Rhinitis

NCT00247520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

NCT07091357 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

NCT03755713 ·Status: COMPLETED ·Phase: PHASE1

Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy

NCT05163574 ·Status: UNKNOWN ·Phase: NA

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

NCT01393340 ·Status: COMPLETED ·Phase: PHASE2

Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy

NCT04872218 ·Status: COMPLETED ·Phase: PHASE2

The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy

NCT02745418 ·Status: ACTIVE_NOT_RECRUITING

A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies

NCT01054352 ·Status: COMPLETED ·Phase: PHASE1

Management of Drug Hypersensitivity in Children

NCT02031120 ·Status: TERMINATED

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

NCT07220811 ·Status: RECRUITING ·Phase: PHASE2

Perennial Allergic Rhinitis Study In Pediatric Subjects

NCT00108914 ·Status: COMPLETED ·Phase: PHASE3

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

NCT01307319 ·Status: COMPLETED ·Phase: PHASE3

Peanut Allergy Oral Immunotherapy Desensitization

NCT01601522 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis

NCT05692154 ·Status: COMPLETED ·Phase: PHASE3